Related Experiment Videos
Insights into autoimmunity gained from structural analysis of MHC-peptide complexes
1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Room D1410, 44 Binney Street, Boston, MA 02115, USA. Kai_Wucherpfennig@dfci.harvard.edu
Current Opinion in Immunology
|October 26, 2001
Summary
Human leukocyte antigen (HLA) -DQ and -DR molecules influence autoimmune disease risk. Polymorphisms affect peptide binding, supporting the peptide-antigen driven hypothesis for diseases like type 1 diabetes and rheumatoid arthritis.
Area of Science:
- Immunogenetics
- Molecular immunology
- Autoimmunity
Background:
- Human leukocyte antigen (HLA) -DQ and -DR molecules are key players in immune responses.
- These molecules are associated with susceptibility to common autoimmune diseases, including type 1 diabetes, rheumatoid arthritis, and multiple sclerosis.
- Understanding their structural and functional properties is crucial for deciphering disease mechanisms.
Purpose of the Study:
- To define the structural and functional properties of HLA-DQ and -DR molecules linked to autoimmune disease susceptibility.
- To investigate the impact of relevant polymorphisms on peptide interaction and T cell receptor (TCR) recognition.
- To provide evidence supporting the peptide-antigen driven hypothesis in autoimmune diseases.
Main Methods:
- Analysis of structural and functional properties of HLA-DQ and -DR molecules.
- Examination of polymorphisms within HLA genes.
- Evaluation of peptide binding and TCR recognition in the context of autoimmune disease.
Main Results:
- Defined structural and functional characteristics of HLA-DQ and -DR molecules associated with autoimmune disease risk.
- Demonstrated that polymorphisms directly influence peptide interaction.
- Provided strong support for the hypothesis that autoimmune diseases are peptide-antigen driven.
Conclusions:
- The structural and functional properties of HLA-DQ and -DR molecules are critical in autoimmune disease susceptibility.
- Polymorphisms in these HLA molecules significantly impact peptide binding and TCR recognition.
- Structural modifications of peptides should be considered when analyzing T cell responses in autoimmune diseases.